Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression

Abstract Background Reliable biomarkers for predicting disease progression in multiple sclerosis (MS) are crucial for advancing precision medicine and optimising treatment strategies. This study evaluates the predictive potential of serum nuclear magnetic resonance (NMR)-based metabolomics, individu...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Tereza Kacerova, Eline Willemse, Johanna Oechtering, Daniel E. Radford-Smith, Wenzheng Xiong, Megan Sealey, Luisa Saldana, Aleksandra Maleska Maceski, Tianrong Yeo, Gabriele DeLuca, Jacqueline Palace, David Leppert, Jens Kuhle, Daniel C. Anthony, Fay Probert
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Nature Portfolio 2026-02-01
Цуврал:	Communications Medicine
Онлайн хандалт:	https://doi.org/10.1038/s43856-026-01453-5
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!